BridgeBio Pharma Inc
NASDAQ:BBIO

Watchlist Manager
BridgeBio Pharma Inc Logo
BridgeBio Pharma Inc
NASDAQ:BBIO
Watchlist
Price: 23.42 USD 0.77% Market Closed
Market Cap: 4.4B USD
Have any thoughts about
BridgeBio Pharma Inc?
Write Note

Income Statement

Earnings Waterfall
BridgeBio Pharma Inc

Revenue
217.8m USD
Cost of Revenue
-2.4m USD
Gross Profit
215.4m USD
Operating Expenses
-748.1m USD
Operating Income
-532.7m USD
Other Expenses
93.8m USD
Net Income
-438.9m USD

Income Statement
BridgeBio Pharma Inc

Rotate your device to view
Income Statement
Currency: USD
Dec-2018 Mar-2019 Jun-2019 Sep-2019 Dec-2019 Mar-2020 Jun-2020 Sep-2020 Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023 Mar-2024 Jun-2024 Sep-2024
Revenue
Revenue
0
N/A
0
N/A
0
N/A
27
N/A
41
+52%
41
N/A
41
N/A
22
-46%
8
-62%
9
+6%
63
+620%
57
-9%
70
+22%
71
+2%
91
+28%
89
-2%
78
-12%
78
+0%
6
-93%
9
+66%
9
-1%
219
+2 250%
219
+0%
218
-1%
Gross Profit
Cost of Revenue
0
0
0
(3)
(3)
0
0
0
0
0
(0)
(2)
(3)
(4)
(5)
(4)
(3)
(3)
(3)
(3)
(2)
(2)
(2)
(2)
Gross Profit
0
N/A
0
N/A
0
N/A
24
N/A
38
+57%
0
N/A
0
N/A
0
N/A
8
N/A
0
N/A
54
N/A
55
+2%
67
+22%
67
0%
86
+29%
84
-2%
74
-12%
75
+1%
3
-96%
7
+128%
7
-1%
216
+3 053%
217
+0%
215
-1%
Operating Income
Operating Expenses
(184)
(204)
(238)
(275)
(302)
(346)
(401)
(448)
(483)
(548)
(572)
(594)
(643)
(627)
(624)
(597)
(543)
(515)
(514)
(551)
(606)
(689)
(720)
(748)
Selling, General & Administrative
(44)
(54)
(61)
(74)
(94)
(110)
(131)
(143)
(146)
(157)
(165)
(175)
(192)
(191)
(181)
(166)
(143)
(131)
(130)
(135)
(151)
(185)
(209)
(242)
Research & Development
(140)
(147)
(178)
(202)
(208)
(233)
(268)
(304)
(337)
(391)
(407)
(419)
(451)
(436)
(443)
(431)
(399)
(385)
(384)
(416)
(456)
(504)
(511)
(506)
Other Operating Expenses
0
(2)
0
0
0
(3)
(3)
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Operating Income
(184)
N/A
(204)
-11%
(238)
-17%
(251)
-5%
(264)
-5%
(305)
-16%
(361)
-18%
(426)
-18%
(474)
-11%
(540)
-14%
(509)
+6%
(539)
-6%
(577)
-7%
(560)
+3%
(538)
+4%
(513)
+5%
(468)
+9%
(440)
+6%
(511)
-16%
(544)
-7%
(599)
-10%
(473)
+21%
(503)
-6%
(533)
-6%
Pre-Tax Income
Interest Income Expense
(1)
(5)
(10)
(15)
(21)
(19)
(23)
(27)
(33)
(40)
(41)
(41)
(46)
(56)
43
36
35
40
(63)
(67)
(45)
(41)
(52)
(57)
Non-Reccuring Items
19
17
17
17
(2)
0
0
0
0
0
0
0
0
(23)
(31)
(36)
(44)
(24)
(20)
(15)
(8)
(35)
92
140
Total Other Income
(4)
(5)
(4)
(4)
(1)
1
(1)
(2)
2
7
11
11
36
22
9
16
(8)
(2)
9
3
(1)
2
1
3
Pre-Tax Income
(169)
N/A
(196)
-16%
(235)
-20%
(254)
-8%
(289)
-14%
(323)
-12%
(385)
-19%
(455)
-18%
(505)
-11%
(572)
-13%
(538)
+6%
(569)
-6%
(586)
-3%
(617)
-5%
(517)
+16%
(496)
+4%
(485)
+2%
(426)
+12%
(584)
-37%
(623)
-7%
(653)
-5%
(547)
+16%
(462)
+16%
(446)
+3%
Net Income
Income from Continuing Operations
(169)
(196)
(235)
(254)
(289)
(323)
(385)
(455)
(505)
(572)
(538)
(569)
(586)
(617)
(517)
(496)
(485)
(426)
(584)
(623)
(653)
(547)
(462)
(446)
Income to Minority Interest
39
50
38
28
28
32
39
52
57
53
43
34
24
21
8
6
3
1
11
11
10
8
8
7
Net Income (Common)
(131)
N/A
(155)
-18%
(197)
-27%
(226)
-14%
(261)
-15%
(291)
-12%
(346)
-19%
(402)
-16%
(449)
-12%
(520)
-16%
(495)
+5%
(535)
-8%
(563)
-5%
(596)
-6%
(509)
+15%
(491)
+4%
(481)
+2%
(425)
+12%
(573)
-35%
(613)
-7%
(643)
-5%
(538)
+16%
(454)
+16%
(439)
+3%
EPS (Diluted)
-1.14
N/A
-1.34
-18%
-1.89
-41%
-1.92
-2%
-2.48
-29%
-2.47
+0%
-2.94
-19%
-3.41
-16%
-3.8
-11%
-3.75
+1%
-3.37
+10%
-3.65
-8%
-3.9
-7%
-4.08
-5%
-3.49
+14%
-3.31
+5%
-3.26
+2%
-2.78
+15%
-3.56
-28%
-3.75
-5%
-3.95
-5%
-3.01
+24%
-2.41
+20%
-2.32
+4%

See Also

Discover More